Global Non-Small Cell Lung Cancer Therapeutics Market to Reach US$15.1 Bn by 2023, Asia Pacific to Report Fastest CAGR
A research study, recently published by Transparency Market Research (TMR), estimates the global non-small cell lung cancer (NSCLC) therapeutics market to expand at a healthy CAGR of 12.10% over the period from 2015 to 2023 and reach a value of US$15.1 bn by the end of the forecast period.The report, titled "Non Small Cell Lung Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023," states that the worldwide NSCLC market attained US$4.9 bn...
View full press release